Literature DB >> 25257932

International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study.

S Silverman1, J Curtis, K Saag, J Flahive, J Adachi, F Anderson, R Chapurlat, C Cooper, A Diez-Perez, S Greenspan, F Hooven, A Le Croix, L March, J C Netelenbos, J Nieves, J Pfeilschifter, M Rossini, C Roux, E Siris, N Watts, J Compston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25257932      PMCID： PMC4873770          DOI： 10.1007/s00198-014-2883-2

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  9 in total

Review 1.  Current Treatments and New Developments in the Management of Glucocorticoid-induced Osteoporosis.

Authors:  Hennie G Raterman; Irene E M Bultink; Willem F Lems
Journal:  Drugs       Date:  2019-07       Impact factor: 9.546

Review 2.  Management of glucocorticoid-induced osteoporosis.

Authors:  Osvaldo D Messina; Luis Fernando Vidal; Maritza Vidal Vidal; Irene E M Bultink; Hennie G Raterman; William Lems
Journal:  Aging Clin Exp Res       Date:  2021-03-22       Impact factor: 3.636

3.  Fracture rate associated with quality metric-based anti-osteoporosis treatment in glucocorticoid-induced osteoporosis.

Authors:  R A Overman; M L Gourlay; C L Deal; J F Farley; M A Brookhart; J B Layton
Journal:  Osteoporos Int       Date:  2015-01-20       Impact factor: 4.507

4.  Morinda officinalis polysaccharide enable suppression of osteoclastic differentiation by exosomes derived from rat mesenchymal stem cells.

Authors:  Peiyu Wu; Feng Jiao; He Huang; Donghua Liu; Wang Tang; Jie Liang; Wen Chen
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

5.  Osteoporosis prevention among chronic glucocorticoid users: results from a public health insurance database.

Authors:  Sophie Trijau; Gaëlle de Lamotte; Vincent Pradel; François Natali; Véronique Allaria-Lapierre; Hervé Coudert; Thao Pham; Vincent Sciortino; Pierre Lafforgue
Journal:  RMD Open       Date:  2016-07-07

6.  Sodium hydrosulfide alleviates dexamethasone-induced cell senescence and dysfunction through targeting the miR-22/sirt1 pathway in osteoblastic MC3T3-E1 cells.

Authors:  Peng Li; Wei-Wei Mao; Shuai Zhang; Liang Zhang; Zhi-Rong Chen; Zhi-Dong Lu
Journal:  Exp Ther Med       Date:  2021-01-21       Impact factor: 2.447

7.  MicroRNA-22 contributes to dexamethasone-induced osteoblast differentiation inhibition and dysfunction through targeting caveolin-3 expression in osteoblastic cells.

Authors:  Peng Li; Weiwei Mao; Shuai Zhang; Liang Zhang; Zhirong Chen; Zhidong Lu
Journal:  Exp Ther Med       Date:  2021-02-08       Impact factor: 2.447

Review 8.  Glucocorticoid-induced osteoporosis.

Authors:  Karine Briot; Christian Roux
Journal:  RMD Open       Date:  2015-04-08

Review 9.  Glucocorticoid-induced osteoporosis: an update.

Authors:  Juliet Compston
Journal:  Endocrine       Date:  2018-04-24       Impact factor: 3.633
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.